Table 3.
Prevalence of Metabolic Syndrome Components in the Presence of Different Variables (n = 1,032)
| Total |
AOa |
Low HDL-Cb |
High-TGc |
High-BPd |
High-FPGe |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n | n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | |
| Total | 1032 | 306 | 29.7 (26.9–32.4) | 284 | 27.5 (24.8–30.2) | 163 | 15.8 (13.6–18.0) | 143 | 13.9 (11.7–16.0) | 110 | 10.7 (8.8–12.5) |
| Country | |||||||||||
| Mexico | 316 | 86 | 27.2f (22.3–32.1) | 84 | 26.6f (21.7–31.5) | 36 | 11.4f (7.9–14.9) | 52 | 16.5g (12.3–20.6) | 3 | 0.9f (0.2–2.7) |
| Argentina | 76 | 1 | 1.3 (0.03–7.1) | 0 | 0.0 | 10 | 13.2 (5.4–20.9) | 13 | 17.1 (8.4–25.8) | 3 | 3.9 (0.8–11.1) |
| Brazil | 223 | 55 | 24.7 (19.0–30.4) | 42 | 18.8 (13.7–24.0) | 25 | 11.2 (7.0–15.4) | 28 | 12.6 (8.2–16.9) | 16 | 7.2 (3.8–10.6) |
| Colombia | 285 | 89 | 31.2 (25.8–36.6) | 72 | 25.3 (20.2–30.3) | 64 | 22.5 (17.6–27.3) | 25 | 8.8 (5.5–12.1) | 76 | 26.7 (21.5–31.8) |
| Paraguay | 132 | 75 | 56.8 (48.3–65.4) | 86 | 65.2 (56.9–73.4) | 28 | 21.2 (14.1–28.3) | 25 | 18.9 (12.2–25.7) | 12 | 9.1 (4.1–14.1) |
| Sex | |||||||||||
| Male | 290 | 107 | 36.9h (31.3–42.5) | 77 | 26.6 (21.4–31.7) | 74 | 25.5f (20.5–30.6) | 87 | 30.0f (24.7–35.3) | 53 | 18.3f (13.8–22.7) |
| Female | 742 | 199 | 26.8 (23.6–30.0) | 207 | 27.9 (24.7–31.1) | 89 | 12.0 (9.6–14.3) | 56 | 7.5 (5.6–9.4) | 57 | 7.7 (5.8–9.6) |
| Age (years) | |||||||||||
| ≤23 | 401 | 71 | 17.7f (14.0–21.5) | 106 | 26.4 (22.1–30.8) | 41 | 10.2f (7.2–13.2) | 45 | 11.2f (8.1–14.3) | 25 | 6.2f (3.9–8.6) |
| 24–28 | 292 | 75 | 25.7 (20.6–30.7) | 78 | 26.7 (21.6–31.8) | 40 | 13.7 (9.7–17.7) | 25 | 8.6 (5.3–11.8) | 25 | 8.6 (5.3–11.8) |
| ≥29 | 339 | 160 | 47.2 (41.9–52.5) | 100 | 29.5 (24.6–34.4) | 82 | 24.2 (19.6–28.8) | 73 | 21.5 (17.1–25.9) | 60 | 17.7 (13.6–21.8) |
| Health sector | |||||||||||
| Nutrition | 351 | 48 | 13.7f (10.1–17.3) | 70 | 19.9f (15.7–24.1) | 43 | 12.3g (8.8–15.7) | 28 | 8.0f (5.1–10.8) | 31 | 8.8f (5.8–11.8) |
| Medicine | 237 | 113 | 47.7 (41.3–54.1) | 99 | 41.8 (35.4–48.1) | 51 | 21.5 (16.2–26.8) | 36 | 15.2 (10.6–19.8) | 39 | 16.5 (11.7–21.2) |
| Nursing | 134 | 51 | 38.1 (29.7–46.4) | 48 | 35.8 (27.6–44.0) | 19 | 14.2 (8.2–20.2) | 21 | 15.7 (9.4–21.9) | 19 | 14.2 (8.2–20.2) |
| Other areas | 307 | 94 | 30.6 (25.4–35.8) | 67 | 21.8 (17.2–26.5) | 49 | 16.0 (11.8–20.1) | 57 | 18.6 (14.2–22.9) | 20 | 6.5 (3.7–9.3) |
| BMI | |||||||||||
| Underweight | 52 | 0 | 0.0f | 9 | 17.3f (6.7–27.9) | 1 | 1.9f (0.05–10.2) | 2 | 3.8f (0.5–13.2) | 2 | 3.8f (0.5–13.2) |
| Normal weight | 664 | 75 | 11.3 (8.9–13.7) | 152 | 22.9 (19.7–26.1) | 70 | 10.5 (8.2–12.9) | 54 | 8.1 (6.0–10.2) | 47 | 7.1 (5.1–9.0) |
| Overweight | 237 | 152 | 64.1 (58.0–70.3) | 80 | 33.8 (27.7–39.8) | 60 | 25.3 (19.7–30.9) | 53 | 22.4 (17.0–27.7) | 49 | 20.7 (15.5–25.9) |
| Obese | 79 | 79 | 100.0 | 43 | 54.4 (43.2–65.7) | 32 | 40.5 (29.4–51.6) | 34 | 43.0 (31.9–54.2) | 12 | 15.2 (7.1–23.3) |
| Smoking status | |||||||||||
| Nonsmoker | 888 | 251 | 28.3g (25.3–31.2) | 248 | 27.9 (25.0–30.9) | 133 | 15.0h (12.6–17.3) | 113 | 12.7 (10.5–14.9) | 92 | 10.4 (8.3–12.4) |
| Smoker | 76 | 32 | 42.1 (30.7–53.5) | 22 | 28.9 (18.5–39.4) | 13 | 17.1 (8.4–25.8) | 15 | 19.7 (10.6–28.9) | 7 | 9.2 (2.6–15.9) |
| Former smoker | 52 | 18 | 34.6 (21.2–48.0) | 13 | 25.0 (12.8–37.2) | 16 | 30.8 (17.8–43.7) | 11 | 21.2 (9.7–32.6) | 10 | 19.2 (8.1–30.3) |
| PA (min/week) | |||||||||||
| >150 | 975 | 281 | 28.8g (26.0–31.7) | 263 | 27.0 (24.2–29.8) | 153 | 15.7 (13.4–18.0) | 133 | 13.6 (11.5–15.8) | 101 | 10.4 (8.4–12.3) |
| <150 | 57 | 25 | 43.9 30.6–57.1 | 21 | 36.8 (23.9–49.8) | 10 | 17.5 (7.4–27.7) | 10 | 17.5 (7.4–27.7) | 9 | 15.8 (6.0–25.5) |
| PA energy expenditure (kcal/day) | |||||||||||
| ≤317 | 344 | 125 | 36.3h (31.2–41.4) | 96 | 27.9 (23.1–32.7) | 64 | 18.6 (14.5–22.7) | 52 | 15.1 (11.3–18.9) | 40 | 11.6 (8.2–15.0) |
| 318–596 | 344 | 95 | 27.6 (22.9–32.4) | 89 | 25.9 (21.2–30.5) | 42 | 12.2 (8.7–15.7) | 39 | 11.3 (8.0–14.7) | 38 | 11.0 (7.7–14.4) |
| ≥597 | 344 | 86 | 25.0 (20.4–29.6) | 99 | 28.8 (24.0–33.6) | 57 | 16.6 (12.6–20.5) | 52 | 15.1 (11.3–18.9) | 32 | 9.3 (6.2–12.4) |
Taking pharmacological drugs to treat any of these last four disorders was also used as an indicator of this component. Data are expressed as number (n), percentage (%), and 95% CI. The total n in the variable “smoking status” is 1016 and the total n in the variable “health sector” is 1029. The distribution of cases across qualitative variables was analyzed with a chi-squared or Fisher's exact test, according to testing conditions.
AO: waist circumference ≥80 cm in women and ≥90 cm in men.
Low HDL-C: HDL-C <40 mg/dL in men and <50 mg/dL in women.
High-TG: triglycerides ≥150 mg/dL.
High-BP: SBP ≥130 mmHg and/or DBP ≥85 mmHg.
High-FPG: plasma glucose ≥100 mg/dL.
P < 0.001.
P < 0.05.
P < 0.01.
DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure.